New Biomarker Predicts Response to Hepatitis C Treatment – Researchers at Duke University Medical Center have identified the first genetic marker that predicts response to hepatitis C treatments, and a single letter of DNA code appears to make a huge difference.
Is influenzinum right homeopathic remedy for H1N1 flu in India? – There is no doubt that swine flu or Influenza A H1N1 cases are rising in India. Most worrying point is that number of deaths from swine flu also increasing suddenly inspite of all screenings at airports and sea-ports.
Britain’s first swine-flu trials under way — Research led by University of Leicester and University Hospitals of Leicester NHS Trust. – UK’s first swine flu vaccine trials, led by the University of Leicester and University Hospitals of Leicester NHS Trust, are taking place at the Leicester Royal Infirmary.
St. Jude scientists report flu infection leaves brain more vulnerable later in life — Avian influenza strain primes brain for Parkinson’s disease. – At least one strain of the H5N1 avian influenza virus leaves survivors at significantly increased risk for Parkinson’s disease and possibly other neurological problems later in life, according to new research from St. Jude Children’s Research Hospital.
U.S. Food and Drug Administration (FDA) Authorizes Emergency Use of Another Test for 2009 H1N1 Influenza Virus – The U.S. Food and Drug Administration announced it has issued an Emergency Use Authorization (EUA) for a another diagnostic test for the 2009 H1N1 influenza virus, whose spread has caused the virus to be characterized as a pandemic by the World Health Organization.
First three cases of likely HIV transmission to infants via pre-chewed food suggest cautioning HIV-positive caregivers against prechewing food. – Researchers have uncovered the first cases in which HIV almost certainly was transmitted from mothers or other caregivers to children through pre-chewed food.
NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates – Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines.
U.S. Food and Drug Administration (FDA) Approves Vaccine for 2009-2010 Seasonal Influenza. – The U.S. Food and Drug Administration announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States. The seasonal influenza vaccine will not protect against the 2009 H1N1 influenza virus.
HHS Purchases Additional H1N1 Vaccine Ingredients – U.S. Department of Health & Human Services’ Secretary Kathleen Sebelius announced that the health department will commit $884 million to purchase additional supplies of two key ingredients for potential H1N1 vaccine to further prepare the nation for a potential resurgence of the 2009 H1N1 virus.
Study may explain why HIV progresses faster in women than in men with same viral load — Pathways related to elevated immune activation could lead to new treatment strategies. – One of the continuing mysteries of the HIV/AIDS epidemic is why women usually develop lower viral levels than men following acute HIV-1 infection but progress faster to AIDS than men with similar viral loads.
Obama Administration Calls on Nation to Begin Planning and Preparing for Fall Flu Season & the New H1N1 Virus – In US, the Obama Administration sent a strong message to the nation that it is time to start planning and preparing for the fall flu season and the ongoing H1N1 flu outbreak.
The World Health Organization grants prequalification to Cervarix: GSK?s vaccine to help combat cervical cancer in developing nations. – The World Health Organization (WHO) has awarded prequalification to Cervarix, GlaxoSmithKline’s cervical cancer vaccine. GlaxoSmithKline pharmaceutical company applied for WHO prequalification of Cervarix 2 years ago.
